Political battle looms over US CMS cuts

11 February 2008

A new season of political battles over the future of US health care spending has opened with the call by the Speaker of the House of Representatives, Nancy Pelosi (Democrat, California), to resist a final attempt by President George W Bush to restrict spending by the Centers for Medicare and Medicaid Services (CMS). The President's proposals are outlined in the draft budget for fiscal 2009.

Rep Pelosi said: "the President is proposing to once again slash health care coverage for seniors and low-income working Americans. The President's cuts are exactly the wrong medicine when the cost of health care and the number of uninsured continue to rise and families are feeling economically insecure."

One battleground will be the subsidy paid by the federal government for Medicare Advantage plans. Although Democrats may approve of at least one feature of the premium health care insurance schemes, namely that brand-name drugs are available to seniors in the "Donut hole" coverage gap (Marketletters passim), the fact that they involve switching from "traditional Medicare" to a privately-managed health plan runs counter to the party's general support for universal insurance with more centralized provision.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight